Skip to content

Dr. PAUL DE LOORE

Active
Private limited companyfounded 1988active for 37 yearsAarschotsesteenweg 8, 2230 Herselt, BelgiumKBO/BCE: BE 0435.771.510
Summary

Dr. PAUL DE LOORE has been active since 1988 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €810,444 and a net result of €190,324. Equity grew by about 8.1% per year on average since 2018. In 2025 it fell by 2%. Its solvency ranks better than 89% of 20,736 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 07-11-1988 Normal situation
Activity
General medical practice NACE 86210
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€293,501
▼ 25.2%
Turnover
≈ €450,000
estimated
Profit
€190,324
▼ 26.8%
Equity
€810,444
▼ 2.0%
Total assets
€869,153
▼ 12.7%
Score breakdownraises riskLiquidity: current ratio 14.04, cash €6,394No registered site in the KBOlowers riskSize: total assets €869,153Sector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 93.2% of total assets
Liquidity 51+5
short-term debt 6.8% · cash 0.7%
Profitability 96-4
return on assets 21.9%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €75,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 14.04 (5.59 in 2024), above the usual 1.5. Short-term debt is 6.8% and cash 0.7% of total assets. 6.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 24% on liquidity, 56% on profitability and 33% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 14.04, cash €6,394
NBB · annual accounts
lowers risk · Size: total assets €869,153
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · No registered site in the KBO
KBO · seat and establishments
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 days early
2024
42 days early
2023
36 days early
2022
59 days early
2021
33 days early
2020
1 day early
2019
4 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 25 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 3rd oldest company in Herselt, Health and social work sectorin the Checked rankings No. 3 View
  • Positive: 8 profitable years in a rowprofit 2025: €190,324 8 years View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View
  • Caution: Result fell in 2025from €259,954 to €190,324 ▼ 26.8% View

Recent changes

  1. · Gazette deed 1 director resigning, 1 director reappointedResignation: Paul DE LOORE (director) · Reappointment: Paul DE LOORE (director) · Permanent representative: Paul DE LOORE
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as Dr. PAUL DE LOORE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €773,000 and €955,000, founded between 1985 and 1994.

CompanyTotal assetsGross margin
Dr. PAUL DE LOORE Herselt€869,153€293,501
Dr. Vermander D. Hoogstraten€772,551€300,983
VANOMED Harelbeke€942,754€296,878
J. TROUBLEYN Maaseik€870,876€280,328
DR. ROB SMEETS Zutendaal€954,724€305,919
Dokters Van De Bruaene - Pattyn Deerlijk€849,521€275,326
Dr. Van Cauteren André, huisarts, verzekeringsgeneeskunde en medische expertise Sint-Niklaas€796,872€266,700
Full comparison

Key facts about Dr. PAUL DE LOORE

What is the company number of Dr. PAUL DE LOORE?
The company number of Dr. PAUL DE LOORE is 0435.771.510. The VAT number is the same number with BE in front: BE 0435.771.510.
Where is Dr. PAUL DE LOORE based?
The registered office is at Aarschotsesteenweg 8, 2230 Herselt.Company details
What does Dr. PAUL DE LOORE do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. PAUL DE LOORE?
Dr. PAUL DE LOORE is a private limited company (BV).
When was Dr. PAUL DE LOORE founded?
Dr. PAUL DE LOORE was founded on 07-11-1988.
Is Dr. PAUL DE LOORE still active?
Yes, Dr. PAUL DE LOORE is an active enterprise in the KBO register.
What is the turnover of Dr. PAUL DE LOORE?
The turnover in financial year 2025 is ≈ €450,000. This figure is estimated from the gross margin of €293,501 and 36 comparable companies (NACE 862). It probably lies between €410,000 and €570,000.Financials
Is Dr. PAUL DE LOORE profitable?
In financial year 2025, Dr. PAUL DE LOORE made a profit of €190,324.
Where can I find the annual accounts of Dr. PAUL DE LOORE?
Dr. PAUL DE LOORE filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. PAUL DE LOORE due?
Dr. PAUL DE LOORE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.